286.20
Cencora Inc 주식(COR)의 최신 뉴스
Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel - GlobeNewswire Inc.
What are the latest earnings results for Cencora Inc.Superior trading gains - jammulinksnews.com
How volatile is Cencora Inc. stock compared to the marketCapitalize on market momentum for big wins - jammulinksnews.com
What are analysts’ price targets for Cencora Inc. in the next 12 monthsInvest smarter with actionable trading signals - jammulinksnews.com
What catalysts could drive Cencora Inc. stock higher in 2025Breakout stock performance - jammulinksnews.com
Why Cencora Inc. stock is on top investor watchlistsCapital Safe Stock Watchlist - beatles.ru
Cencora (NYSE:COR) shareholders have earned a 25% CAGR over the last five years - Yahoo Finance
What drives Cencora Inc. stock priceDynamic capital growth - PrintWeekIndia
What institutions are buying Cencora Inc. stock nowBreakout stock performance - jammulinksnews.com
What analysts say about Cencora Inc. stockFree Stock Market Query - PrintWeekIndia
How Cencora Inc. stock compares to its top competitorsIs VBTX stock undervalued or overvalued nowRapid wealth multiplication - jammulinksnews.com
Cencora Inc. Stock Analysis and ForecastBreakthrough wealth creation - PrintWeekIndia
How high can Cencora Inc. stock price go in 2025Fastest-growing stock picks - jammulinksnews.com
Will Cencora Inc. stock split in the near futureMarket-crushing stock picks - jammulinksnews.com
Cencora, Inc. (COR): A Bull Case Theory - Insider Monkey
Is Cencora Inc. a good long term investmentExplosive trading opportunities - jammulinksnews.com
Why Cencora Inc. stock attracts strong analyst attentionFree Stock Market Insider Analysis - beatles.ru
Here's What to Expect From Cencora's Next Earnings Report - MSN
Cencora, Inc. shares rise 2.42% after-hours following Citius Oncology's $9.0 million public offering. - AInvest
Cencora Slumps to 447th in Market Rankings as Trading Volume Drops 40.48 Percent - AInvest
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Cencora Surges to 261st in Daily Rankings with 3.90 Billion Trading Volume - AInvest
Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - BioSpace
Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st
Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener
Cencora distribution deal boosts Citius shares - MSN
Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia
Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha
자본화:
|
볼륨(24시간):